Brigitte Onteniente
CEO/President
- Phenocell SIS
Professional Information
Brigitte
Onteniente
CEO/President
Phenocell SIS
Research
Education, Honors & Awards
Shiga University of Medical Science, Japan; University of Bordeaux
Post Doctorate Degree in Physiopathology of the Limbic System from Shiga University of Medical Science, Japan (1983); PhD in Neurophysiology from the University from the University of Bordeaux (1987)
1987
"Emergence" & "Development & Creation" from French Research & Higher Education Ministry
Personal Information
France
Evry Cedex
Member of the School of Management, Haute Ecole Commerce (HEC)
Yoga; Reading
1-5 Years
Brigitte Onteniente speaks publicly about her company, Phenocell, their purpose, stem sells, and drug discovery. Dr. Onteniente's work has been published in several journals. She built and coordinated the STEMS European project after a sabbatical year in Southampton University. She is fuent in French and English. Phenocell aims at accelerating the development of innovative therapies for rare diseases. With the unique technology of cell reprogramming, the company creates, produces and commercializes unique cellular models for orphan drug discovery. We develop specific phenotype assays for the understanding of pathogenic mechanisms, drug discovery and ADME-T studies. Phenocell's iPSC and differentiated cellular models are designed to perfectly fit with the requirements of academic and industrial research.
Creation Production & Commercialization of Cellular Models for Research & Drug Discovery; Neurological Science- Skin, Aging, & Neurological Disease